Indications and Long-Term Outcomes of Using Mycophenolate Mofetil Monotherapy in Substitution for Calcineurin Inhibitors in Liver Transplantation

Indications and Long-Term Outcomes of Using Mycophenolate Mofetil Monotherapy in Substitution for Calcineurin Inhibitors in Liver Transplantation

Switching the use of calcineurin inhibitors (CNIs), as basal immunosuppression in liver transplantation (LT) patients, for that of mycophenolate mofetil monotherapy (MMF-MT) is currently considered a good measure in recipients with chronic kidney disease (CKD) and other CNI-related adverse effects....

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos Jiménez-Romero, Iago Justo Alonso, Oscar Caso Maestro, Alejandro Manrique Municio, Álvaro García-Sesma, Jorge Calvo Pulido, Félix Cambra Molero, Carmelo Loinaz Segurola, Cristina Martín-Arriscado, Anisa Nutu, Alberto Marcacuzco Quinto
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Transplant International
Subjects:
mycophenolate mofetil
tacrolimus
cyclosporine
immunosuppression minimization
liver transplantation
chronic kidney dysfunction
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2025.13790/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontierspartnerships.org/articles/10.3389/ti.2025.13790/full

Similar Items